Crizotinib in the management of advanced-stage non-small-cell lung cancer. [electronic resource]
Producer: 20151120Description: 735-45 p. digitalISSN:- 1744-8301
- Antineoplastic Agents -- chemistry
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Clinical Trials, Phase I as Topic
- Clinical Trials, Phase II as Topic
- Clinical Trials, Phase III as Topic
- Crizotinib
- Disease Management
- Drug Resistance, Neoplasm -- genetics
- Gene Amplification
- Humans
- Lung Neoplasms -- drug therapy
- Neoplasm Staging
- Oncogene Proteins, Fusion -- genetics
- Protein Kinase Inhibitors -- chemistry
- Protein-Tyrosine Kinases -- genetics
- Proto-Oncogene Proteins -- genetics
- Proto-Oncogene Proteins c-met -- genetics
- Pyrazoles -- chemistry
- Pyridines -- chemistry
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.